Drugs for schizophrenia tested in teens

Published: March. 3, 2008 at 9:42 PM

MINNEAPOLIS, March 3 (UPI) -- The long-term risk of clozapine and olanzapine need to be weighed against potential benefits for teens and children with schizophrenia, a U.S. study said.

Study author Dr. Sanjiv Kumra of the University of Minnesota in Minneapolis recruited 39 children ages 10 to 18 who had already failed to respond to at least two anti-psychotic treatments, to participate in a 12-week, double-blind, randomized study of clozapine or "high dose" olanzapine. High dose refers to doses exceeding package insert recommendations.

The study, published in Biological Psychiatry, found clozapine to be approximately twice as likely as olanzapine to produce a treatment response.

Kumra reported both medications "produced significant weight gain and associated metabolic abnormalities," but without these drugs the result would likely be long-term institutional care or early death.

Additional research will be needed to follow-up on this preliminary finding, Kumra said.

© 2008 United Press International, Inc. All Rights Reserved.
Order reprints



Additional News Stories
Watercooler Stories (13 min)
Jockstrip: The world as we know it. (43 min)
Your Daily Horoscope
The almanac
UPI Sports Calendar for Tuesday, Nov. 24
Hiring rivals' workers can be an advantage
NBA: Los Angeles Clippers 91, Minnesota 87
fark
The more germs a child is exposed to during early childhood, the better their immune system in later...
Kirk Camerowned
Photoshop this hypno-gizmo
Nearly six-in-ten Mexicans say living in the U.S. is much better than back in Old Mexico. Lou Dobbs'...
Charges dropped against dad who drove a drunken intruder away from his wife and young kids... with...
The Public Option, which was alive, then dead, then alive, then dead, then alive, then dead, then...